Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020252 · ClinicalTrials.gov registry record
Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 120
- Enrollment target
NCT02020252: Completed study, sponsored by University of Chicago.
NCT02020252 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02020252 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of this research study is to test a touchscreen computer program, which allows patients to see information on a computer screen regarding cancer care, and specifically clinical trials. The purpose of this research is to help the investigators learn more about how to use technology in the medical setting to improve health outcomes.
Primary Outcome
We hypothesized that our interactive educational tool would improve patient receptivity, willingness, knowledge, self-efficacy and positive attitudes regarding therapeutic cancer clinical trials through the use of patient-friendly technology in the immediate pre-visit period. Patients used the TT to self-administer 24 items from the Clinical Trial questionnaire developed by Jacobsen and colleagues measuring Receptivity (range: 1-5), Willingness (range: 1-5), Knowledge about cancer clinical trial
Interventions
- BEHAVIORAL Testing an interactive technology in a diverse health literary population
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-11-26 |
| Est. Completion | 2018-12 |
What the finished NCT02020252 record still lists
NCT02020252 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Testing an interactive technology in a diverse health literary population is the first listed.
NCT02020252 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02020252 about?
NCT02020252 is a clinical study titled "Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials". The purpose of this research study is to test a touchscreen computer program, which allows patients to see information on a computer screen regarding cancer care, and specifically clinical trials. The purpose of this research is to help the investigators learn more about how to use technology in the...
What is the current status of trial NCT02020252?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2013-11-26. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02020252?
The interventions under investigation include: Testing an interactive technology in a diverse health literary population (BEHAVIORAL).
Who is sponsoring clinical trial NCT02020252?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI